Uke 17: Once versus twice daily enoxaparin for the initial treatment of acute venous thromboembolism
Essentials• In venous thromboembolism (VTE), it is uncertain if enoxaparin should be given twice or once daily.
• We compared the 15- and 30-day outcomes in VTE patients on enoxaparin twice vs. once daily.
• Patients on enoxaparin once daily had fewer major bleeds and deaths than those on twice daily.
• The rate of VTE recurrences was similar in both subgroups.
• We compared the 15- and 30-day outcomes in VTE patients on enoxaparin twice vs. once daily.
• Patients on enoxaparin once daily had fewer major bleeds and deaths than those on twice daily.
• The rate of VTE recurrences was similar in both subgroups.